Pacific Biosciences Of California, Inc.
PACB
Revenue
36.01M
▼-2.80M▼-7.21%
3 Months ChangeAssets
1.51B
▼-160.43M▼-9.61%
3 Months ChangeLiabilities
1.02B
▼-4.11M▼-0.4028%
3 Months ChangeFree Cash Flow
-79.56M
▲18.85M▲19.16%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0001299130-24-000169
2024-08-07
Form 8-K
ID: 0001299130-24-000164
2024-06-20
Form 8-K
ID: 0001299130-24-000146
2024-05-09
Form 10-Q
ID: 0001299130-24-000111
2024-05-09
Form 8-K
ID: 0001299130-24-000109
2024-04-16
Form 8-K
ID: 0001104659-24-047511
2024-02-15
Form 8-K
ID: 0001299130-24-000014
2024-01-08
Form 8-K
ID: 0001299130-24-000005
2023-12-11
Form 8-K
ID: 0001299130-23-000142
2023-11-03
Form 10-Q
ID: 0001299130-23-000139